Investors are starting to get worried now that COVID-19 is possibly declining.
News & Analysis: Quidel
The company released its fourth-quarter and full-year 2020 earnings report.
The diagnostics company delivered impressive top- and bottom-line growth. But it wasn't enough to fire up investors.
QDEL earnings call for the period ending December 31, 2020.
The need for frequent and quick COVID-19 testing ensures that demand for its products won't slow down anytime soon.
Companies continue to develop new tests to detect COVID-19.
One of the company's COVID-19 tests received emergency use authorization.
A new point-of-care test is both fast and accurate.
Although vaccine makers are dominating headlines, these diagnostic companies will remain relevant in the fight against COVID-19.
The COVID-19 testing landscape is changing. Will that sap the growth of the incumbent leaders?